Publicaciones (69) Publicaciones en las que ha participado algún/a investigador/a

2001

  1. 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose

    Psychopharmacology, Vol. 154, Núm. 3, pp. 251-260

  2. 3-D-QSAR/CoMFA and recognition models of benzimidazole derivatives at the 5-HT(4) receptor

    Bioorganic and medicinal chemistry letters, Vol. 11, Núm. 21, pp. 2807-2811

  3. A neurotoxic dose of 3, 4-methylenedioxymethamphetamine (MDMA; ecstasy) to rats results in a long term defect in thermoregulation

    Psychopharmacology, Vol. 155, Núm. 4, pp. 413-418

  4. A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine neurones in mouse brain

    British Journal of Pharmacology, Vol. 134, Núm. 8, pp. 1711-1723

  5. Adenosine monophosphate-activated protein kinase mediates the protective effects of ischemic preconditioning on hepatic ischemia-reperfusion injury in the rat

    Hepatology, Vol. 34, Núm. 6, pp. 1164-1173

  6. Adenosine triphosphate and diadenosine pentaphosphate induce [Ca2+]i increase in rat basal ganglia aminergic terminals

    Journal of Neuroscience Research, Vol. 64, Núm. 2, pp. 174-182

  7. African swine fever virus protein p54 interacts with the microtubular motor complex through direct binding to light-chain dynein

    Journal of Virology, Vol. 75, Núm. 20, pp. 9819-9827

  8. An activity-dependent switch from facilitation to inhibition in the control of excitotoxicity by group I metabotropic glutamate receptors

    European Journal of Neuroscience, Vol. 13, Núm. 8, pp. 1469-1478

  9. Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration

    Journal of Neurochemistry, Vol. 78, Núm. 6, pp. 1415-1427

  10. Biochemical, electrophysiological and neurohormonal studies with B-20991, a selective 5-HT1A receptor agonist

    Pharmacology, Vol. 62, Núm. 4, pp. 234-242

  11. Calcium channel types involved in intrinsic amino acid neurotransmitters release evoked by depolarizing agents in cortical neurons

    Neurochemistry International, Vol. 39, Núm. 4, pp. 283-290

  12. Cardiac effects of diinosine tetraphosphate, a putative dinucleotide receptor antagonist

    Drug Development Research, Vol. 52, Núm. 3, pp. 500-503

  13. Ceramide: A new second messenger of cannabinoid action

    Trends in Pharmacological Sciences, Vol. 22, Núm. 1, pp. 19-22

  14. Cerebellar astrocytes coexpress different purinoceptors: Cross-talk between several transduction mechanisms

    Drug Development Research

  15. Changes in cannabinoid CB1 receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis

    Synapse, Vol. 41, Núm. 3, pp. 195-202

  16. Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington's disease

    NeuroReport, Vol. 12, Núm. 10, pp. 2125-2129

  17. Chemical mechanism of β-xylosidase from Trichoderma reesei QM 9414: pH-dependence of kinetic parameters

    Biochimie, Vol. 83, Núm. 10, pp. 961-967

  18. Cloning, expression, and purification of Histidine-tagged preS domains of hepatitis B virus

    Protein Expression and Purification, Vol. 21, Núm. 1, pp. 183-191

  19. Computational model of the complex between GR113808 and the 5-HT4 receptor guided by site-directed mutagenesis and the crystal structure of rhodopsin

    Journal of Computer-Aided Molecular Design, Vol. 15, Núm. 11, pp. 1025-1033

  20. Control of the cell survival/death decision by cannabinoids

    Journal of Molecular Medicine, Vol. 78, Núm. 11, pp. 613-625